5686.0000 38.50 (0.68%)
NSE Dec 04, 2025 11:28 AM
Volume: 13,902
 

5686.00
0.68%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended